NO20014223L - Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer - Google Patents

Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer

Info

Publication number
NO20014223L
NO20014223L NO20014223A NO20014223A NO20014223L NO 20014223 L NO20014223 L NO 20014223L NO 20014223 A NO20014223 A NO 20014223A NO 20014223 A NO20014223 A NO 20014223A NO 20014223 L NO20014223 L NO 20014223L
Authority
NO
Norway
Prior art keywords
diagnosis
monitoring
procedure
breast carcinomas
malignant breast
Prior art date
Application number
NO20014223A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014223D0 (no
Inventor
Charles F Streckfus
Lenora G Bigler
James Tate Thigpen
Original Assignee
Univ Mississippi Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mississippi Medical Ct filed Critical Univ Mississippi Medical Ct
Publication of NO20014223D0 publication Critical patent/NO20014223D0/no
Publication of NO20014223L publication Critical patent/NO20014223L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20014223A 1999-03-01 2001-08-31 Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer NO20014223L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/259,993 US6294349B1 (en) 1999-03-01 1999-03-01 Method of diagnosing and monitoring malignant breast carcinomas
PCT/US2000/005364 WO2000052463A1 (fr) 1999-03-01 2000-03-01 Methode permettant de diagnostiquer et de surveiller des carcinomes mammaires malins

Publications (2)

Publication Number Publication Date
NO20014223D0 NO20014223D0 (no) 2001-08-31
NO20014223L true NO20014223L (no) 2001-10-23

Family

ID=22987369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014223A NO20014223L (no) 1999-03-01 2001-08-31 Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer

Country Status (11)

Country Link
US (3) US6294349B1 (fr)
EP (1) EP1161680A4 (fr)
JP (1) JP2002538462A (fr)
CN (1) CN1349611A (fr)
AU (1) AU3613400A (fr)
BR (1) BR0008709A (fr)
CA (1) CA2363566A1 (fr)
HK (1) HK1044816A1 (fr)
MX (1) MXPA01008794A (fr)
NO (1) NO20014223L (fr)
WO (1) WO2000052463A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294349B1 (en) * 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US20060204958A1 (en) * 2002-05-17 2006-09-14 Eastern Virginia Medical School Methods for diagnosing htlv-i-mediated diseases
US20040033613A1 (en) * 2002-05-30 2004-02-19 Zwick Michael G. Saliva-based protein profiling
EP1651095A4 (fr) * 2003-08-05 2008-10-08 Euro Celtique Sa Procedes et kits lies au recepteur erbb et permettant de controler la resistance a la chimiotherapie
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20050106642A1 (en) * 2003-11-19 2005-05-19 Lipps Binie V. Saliva test for early diagnosis of cancers
US20050186215A1 (en) * 2004-02-04 2005-08-25 Kwok Tim T. CUDR as biomarker for cancer progression and therapeutic response
US10072297B2 (en) * 2004-02-20 2018-09-11 The Regents Of The University Of California Salivary mRNA profiling, biomarkers and related methods
US7964408B1 (en) 2004-05-13 2011-06-21 University Of South Florida Lysophospholipids as biomarkers of ovarian cancer
CA2567987A1 (fr) * 2004-06-18 2005-12-29 Gabriele Pestlin Utilisation de la proteine pdx1 comme marqueur pour le cancer du sein
WO2006012361A2 (fr) * 2004-07-01 2006-02-02 University Of Southern California Marqueurs genetiques de prediction de maladies et resultat therapeutique
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2006034032A2 (fr) * 2004-09-17 2006-03-30 The Johns Hopkins University Marqueurs biologiques destines au cancer du sein
US7504225B2 (en) * 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
CA2620964A1 (fr) * 2005-09-14 2007-03-22 The Regents Of The University Of California Proteine et arn salivaires permettant la detection du cancer du sein
KR100828539B1 (ko) * 2005-09-20 2008-05-13 후지제롯쿠스 가부시끼가이샤 이차원 코드의 검출 방법, 검출 장치, 및 검출 프로그램을기억한 기억 매체
WO2007048107A2 (fr) * 2005-10-19 2007-04-26 Heska Corporation Profilage protéomique de tumeurs de cellule souche et procédés associés, protéines et molécules d’acide nucléique
US7662580B2 (en) 2005-11-10 2010-02-16 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
CA2681933A1 (fr) 2006-04-03 2007-11-08 Dorothee Goldman Procedes et kit pour criblage d'endometriose
JP5399900B2 (ja) * 2006-06-30 2014-01-29 メルク・シャープ・アンド・ドーム・コーポレーション Ｉｇｆｂｐ２インヒビター
WO2008088343A1 (fr) * 2007-01-19 2008-07-24 Biophysical Corporation Procedes de fourniture de service d'evaluation d'etat de sante individualise
US20120156687A1 (en) * 2007-04-03 2012-06-21 Chinmay Prakash Soman Nanoparticles with molecular recognition elements
US20100279419A1 (en) * 2007-09-18 2010-11-04 Board Of Regents Of The University Of Texas System Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast
CN101234026B (zh) * 2008-03-07 2010-04-14 李立 一种乳腺病变定量化影像评价系统
US20130116343A1 (en) * 2010-04-21 2013-05-09 Board Of Regents Of The University Of Texas System Salivary Protein Markers for Detection of Breast Cancer
WO2012024095A2 (fr) 2010-08-20 2012-02-23 Oratel Diagnostics, Llc Surveillance de cycle œstral par réponse colorée
ES2679995T3 (es) 2011-03-11 2018-09-03 Vib Vzw Moléculas y métodos para la inhibición y detección de proteínas
WO2013009813A1 (fr) 2011-07-11 2013-01-17 Oratel Diagnostics, Llc Méthodes et kit de diagnostic de l'endométriose
CA2855971C (fr) 2011-11-15 2022-01-04 Elizabeth Franzmann Procedes pour detecter des papillomavirus humains et obtenir un pronostic pour un carcinome malpighien de la tete et du cou
CN104142397A (zh) * 2014-08-06 2014-11-12 厦门大学 胸腺素alpha原在制备乳腺癌诊断标记物中的应用
US20180031543A1 (en) * 2015-02-09 2018-02-01 Abogen, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis
JP2017211886A (ja) * 2016-05-26 2017-11-30 株式会社ブラケアジェネティクス 女性の健康増進に有用なカスタマイズ情報の提供システム
WO2018098379A1 (fr) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Procédés de détection du cancer
JP2020521452A (ja) 2017-05-24 2020-07-27 パンディオン・セラピューティクス・インコーポレイテッド 標的化免疫寛容
WO2019078545A1 (fr) * 2017-10-16 2019-04-25 헨리기술 주식회사 Kit de détection du cancer du sein utilisant de la salive et procédé de détection du cancer du sein l'utilisant, et kit de détection de fenêtre fertile utilisant de la salive et procédé de détection de fenêtre fertile l'utilisant
KR102018171B1 (ko) * 2017-10-16 2019-09-04 헨리기술 주식회사 타액을 이용한 유방암 감지 키트 및 이를 이용한 유방암 감지 방법
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
US10174091B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
US11078256B2 (en) 2018-06-26 2021-08-03 The Board Of Regents Of The University Of Texas System Methods and compositions for inhibiting cancer cell growth
JP2022533702A (ja) 2019-05-20 2022-07-25 パンディオン・オペレーションズ・インコーポレイテッド ＭＡｄＣＡＭ標的化免疫寛容
CN110297082A (zh) * 2019-06-12 2019-10-01 杭州启创生物技术有限公司 唾液尿酸等标志物特异性检测和诊断痛风的方法
US11981715B2 (en) 2020-02-21 2024-05-14 Pandion Operations, Inc. Tissue targeted immunotolerance with a CD39 effector

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401638A (en) 1986-06-04 1995-03-28 Oncogene Science, Inc. Detection and quantification of neu related proteins in the biological fluids of humans
US5512657A (en) 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5527676A (en) * 1989-03-29 1996-06-18 The Johns Hopkins University Detection of loss of the wild-type P53 gene and kits therefor
ATE207958T1 (de) * 1989-08-04 2001-11-15 Schering Ag Äusserliche domäne von c-erbb-2:gp75
RO115498B1 (ro) 1993-10-29 2000-03-30 Univ Boston Metoda de tratament a neoplasmului
WO1996012187A1 (fr) * 1994-10-13 1996-04-25 Horus Therapeutics, Inc. Procedes assistes par ordinateur de diagnostic de maladies
US5840889A (en) 1996-04-19 1998-11-24 The Board Of Regents Of The University Of Nebraska Synthesis of estrogen-purine base and estrogen-mercapturate adducts and development of fluorescent probes and monoclonal antibodies to assay those adducts
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US7393823B1 (en) 1999-01-20 2008-07-01 Oregon Health And Science University HER-2 binding antagonists
US6294349B1 (en) * 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas

Also Published As

Publication number Publication date
US6670141B2 (en) 2003-12-30
CA2363566A1 (fr) 2000-09-08
HK1044816A1 (zh) 2002-11-01
JP2002538462A (ja) 2002-11-12
WO2000052463A9 (fr) 2002-04-11
MXPA01008794A (es) 2003-07-28
AU3613400A (en) 2000-09-21
US6294349B1 (en) 2001-09-25
NO20014223D0 (no) 2001-08-31
EP1161680A1 (fr) 2001-12-12
US20020015964A1 (en) 2002-02-07
CN1349611A (zh) 2002-05-15
BR0008709A (pt) 2001-12-18
EP1161680A4 (fr) 2002-04-17
US6972180B1 (en) 2005-12-06
WO2000052463A1 (fr) 2000-09-08

Similar Documents

Publication Publication Date Title
NO20014223L (no) Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
NO20030714L (no) Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
NO20024972L (no) Blandinger og fremgangsmater for terapi og diagnose av brystkreft
DE69906008T2 (de) Blutdruckmessgerät
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
AU5481699A (en) Brassieres which facilitate the drainage of lymphatic fluid from the breast areaof the human female
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
NO20014804D0 (no) Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse
IS5035A (is) Aðferðir til varnar gegn brjóstakrabbameini
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
NO20025594L (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft
IT1307016B1 (it) Procedimento e dispositivo per la trasmissione di segnali numerici.
NO20014805D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
EP1183540A4 (fr) Methodes permettant de prevoir et/ou diagnostiquer les risques de cancers gastriques
ITMI991950A0 (it) Procedimento per la sintesi del ritomavir
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
NO996166L (no) FremgangsmÕte for behandling av avluter
TR199900070A3 (tr) Naftiridonlarin ve ara baglarin hazirlanmasina yönelik islem.
ZA200108257B (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use.
NO995314D0 (no) For og anvendelse av slikt for

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application